New Gene Therapy Could Face Uphill Battle
The potential FDA approval of BioMarin’s gene therapy for hemophilia A would be a major win, but patient uptake could ...
The potential FDA approval of BioMarin’s gene therapy for hemophilia A would be a major win, but patient uptake could ...